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Abstract
Background:  Glutamate receptors of the AMPA type (AMPArs) mediate fast excitatory
transmission in the dorsal horn and are thought to underlie perception of both acute and chronic
pain. They are tetrameric structures made up from 4 subunits (GluR1-4), and subunit composition
determines properties of the receptor. Antigen retrieval with pepsin can be used to reveal the
receptors with immunocytochemistry, and in this study we have investigated the subunit
composition at synapses within laminae I–III of the dorsal horn. In addition, we have compared
staining of AMPArs with that for PSD-95, a major constituent of glutamatergic synapses. We also
examined tissue from knock-out mice to confirm the validity of the immunostaining.
Results:  As we have shown previously, virtually all AMPAr-immunoreactive puncta were
immunostained for GluR2. In laminae I–II, ~65% were GluR1-positive and ~60% were GluR3-
positive, while in lamina III the corresponding values were 34% (GluR1) and 80% (GluR3). Puncta
stained with antibody against the C-terminus of GluR4 (which only detects the long form of this
subunit) made up 23% of the AMPAr-containing puncta in lamina I, ~8% of those in lamina II and
46% of those in lamina III. Some overlap between GluR1 and GluR3 was seen in each region, but in
lamina I GluR1 and GluR4 were present in largely non-overlapping populations. The GluR4 puncta
often appeared to outline dendrites of individual neurons in the superficial laminae. Virtually all of
the AMPAr-positive puncta were immunostained for PSD-95, and 98% of PSD-95 puncta contained
AMPAr-immunoreactivity. Staining for GluR1, GluR2 and GluR3 was absent in sections from mice
in which these subunits had been knocked out, while the punctate staining for PSD-95 was absent
in mice with a mutation that prevents accumulation of PSD-95 at synapses.
Conclusion: Our results suggest that virtually all glutamatergic synapses in laminae I–III of adult
rat spinal cord contain AMPArs. They show that synapses in laminae I–II contain GluR2 together
with GluR1 and/or GluR3, while the long form of GluR4 is restricted to specific neuronal
populations, which may include some lamina I projection cells. They also provide further evidence
that immunostaining for AMPAr subunits following antigen retrieval is a reliable method for
detecting these receptors at glutamatergic synapses.
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Background
The superficial part of the spinal dorsal horn (laminae I–
II) is the major target for nociceptive primary afferents [1-
3]. It contains numerous excitatory and inhibitory
interneurons, a population of projection cells that are
located in lamina I, and the dorsally directed dendrites of
neurons that have their cell bodies in laminae III and IV
[4-7]. The circuitry of this region is complex and poorly
understood, although it is known that many of these neu-
rons respond to noxious stimulation [8-13] and that the
projection cells appear to be necessary for the develop-
ment of chronic pain states [14,15].
Glutamate is the main excitatory neurotransmitter in the
dorsal horn, and is released by all classes of primary affer-
ent, as well as by the axons of many spinal neurons and by
certain axons that descend from the brain [16,17]. Gluta-
mate acts on both ionotropic and metabotropic receptors,
and these are widely expressed in the spinal cord [18]. In
the dorsal horn, ionotropic receptors of the AMPA type
(AMPArs) mediate fast EPSPs [19,20] and are thought to
play a major role in the perception of both acute and
chronic pain [21,22]. AMPArs have a tetrameric structure
and are made up from four subunits (GluR1-4, also
known as GluR-A-D) that are encoded by four separate
genes, gria1-4. All four subunits are expressed in the dorsal
horn [23-33]. Both homomeric and heteromeric receptors
can be formed, and the properties of the receptors depend
on subunit composition. AMPArs that lack the GluR2 sub-
unit show significant Ca2+-permeability [34], while those
that possess subunits with long C-terminal tails (GluR1
and GluR4) have been shown to undergo activity-depend-
ent insertion, leading to long-term potentiation (LTP)
[35]. In addition, the subunits have specific sites at which
they can undergo phosphorylation, which results in alter-
ations in the channel properties of the receptor [36]. We
have previously demonstrated that acute noxious stimula-
tion results in phosphorylation at the S845 site of GluR1
subunits at synapses in the superficial dorsal horn [33],
and this is likely to lead to an increase in peak open prob-
ability of the receptors, and thus an enhancement of syn-
aptic transmission [37].
Although there are specific antibodies directed against
each of the AMPAr subunits, it is difficult to detect synap-
tic receptors with conventional immunocytochemistry,
because the cross-linking of proteins in the synaptic cleft
and post-synaptic density that occurs during fixation
restricts the access of these antibodies in tissue sections.
Antigen retrieval with pepsin [38] can be used to reveal
synaptic receptors, and we have previously described the
laminar distribution of GluR1-4 at synapses in the rat spi-
nal cord [33]. We reported that GluR2 was widely distrib-
uted throughout the grey matter, and was apparently
present in virtually all synapses that contained AMPArs,
whereas GluR1 was largely restricted to laminae I–III of
the dorsal horn. GluR3 and 4 were found at relatively high
density in deep dorsal horn and ventral horn, but were
also present in some synapses in the superficial laminae.
In this study we have used immunocytochemistry with
antigen retrieval to provide detailed quantitative informa-
tion about the expression of the different AMPAr subunits
at glutamatergic synapses in laminae I–III of the dorsal
horn, and to examine the pattern of co-expression of sub-
units at synapses in this region. In order to identify
AMPAr-containing synapses, we used an antibody that
recognises all four subunits (pan-AMPAr antibody) [39].
One of the main aims was to determine the proportion of
synapses that contained GluR1 and/or GluR4, as this
would give an indication of the extent to which synaptic
plasticity involving these subunits could affect dorsal
horn neurons. To provide further evidence that the immu-
nostaining for AMPArs seen after antigen-retrieval with
pepsin is located at glutamatergic synapses, we compared
it with staining obtained with an antibody against the
post-synaptic density protein PSD-95 [40]. In addition,
we have used spinal cord sections from mice that lacked
the genes for GluR1, 2 or 3 subunits [41,42] or expressed
a mutant form of PSD-95 [43] to demonstrate specificity
of synaptic labelling with the antibodies against these pro-
teins.
Results
Distribution of AMPAr subunits in laminae I–III
Following antigen retrieval with pepsin, a punctate pat-
tern of staining was seen in the dorsal horn with antibod-
ies against each of the GluR subunits and also with the
pan-AMPAr antibody (Fig. 1). The distribution of puncta
seen with the GluR1, GluR2 and GluR3 antibodies was
the same as that reported by Nagy et al. [33]. GluR1
puncta were largely restricted to laminae I–III of the dorsal
horn, while GluR2 puncta were present throughout the
grey matter, but were densest and most strongly stained in
laminae I–II. GluR3-immunoreactive puncta were also
present throughout the grey matter. The majority of those
in laminae I and II were relatively weakly stained com-
pared to puncta in deeper laminae, although scattered
bright puncta were seen in lamina I. However, the rabbit
GluR4 C-terminal antibody (GluR4-C) that was used in
this study gave a different pattern of labelling to that pre-
viously observed in the dorsal horn with a guinea-pig anti-
body against the N-terminus of this subunit (GluR4-N)
[33]. While the N-terminal antibody had labelled many
puncta in the superficial laminae, the C-terminal antibody
labelled few puncta, although these were often relatively
bright and arranged in rows or clusters (Fig. 1 arrow,
arrowhead). When we compared the staining with the 2
GluR4 antibodies directly, we found a population of
puncta that were strongly stained with both the GluR4-NMolecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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and GluR4-C antibodies, as well as many puncta that were
more weakly stained with the GluR4-N antibody but were
not labelled by GluR4-C. All of the puncta stained with
either GluR4 antibody were also GluR2-immunoreactive
(Fig. 2). The distribution of punctate staining with the
pan-AMPAr antibody was very similar to that seen with
the GluR2 antibody (Fig. 1).
Quantification of AMPAr subunits
In sections stained with the pan-AMPAr antibody together
with combinations of subunit-specific antibodies, we
found that all of the puncta that were immunoreactive for
GluR1, 2, 3 or 4 were also pan-AMPAr positive (Fig. 3).
We therefore used the pan-AMPAr antibody to identify
synapses that contained AMPArs and to determine the
proportion of these synapses in each lamina that were
labelled with the GluR1, 3 and 4 antibodies. For each of
these subunits, 100 pan-AMPAr-positive puncta were ana-
lysed from each of laminae I, IIo, IIi and III in sections
from 4 rats (Table 1). We analysed the two halves of lam-
ina II separately, since there are differences in the main
types of primary afferent input to each half, as well as in
the response properties of their neurons [3]. We found
that approximately 65% of the puncta in laminae I–II
were GluR1-immunoreactive, while this proportion
dropped to 34% in lamina III. Between 57–65% of puncta
in laminae I–II were GluR3-positive, rising to 80% in lam-
ina III. In contrast, only a small minority of puncta in the
superficial laminae (23% in lamina I, 7–9% in lamina II)
were positive with the GluR4-C antibody, and the propor-
tion for lamina III was 46%. As expected [33] we found
that virtually all pan-AMPAr-positive puncta were GluR2-
immunoreactive in each of the laminae examined (Fig.
3e–h), and we therefore analysed a sample of 100 pan-
AMPAr puncta located throughout the dorsoventral extent
of laminae I–III in each rat. Between 98–100% (mean
Immunostaining with the pan-AMPAr antibody and with subunit-specific antibodies in laminae I–III of the rat dorsal horn fol- lowing antigen retrieval with pepsin Figure 1
Immunostaining with the pan-AMPAr antibody and with subunit-specific antibodies in laminae I–III of the rat 
dorsal horn following antigen retrieval with pepsin. Each image shows a vertical strip taken through the central part of 
the dorsal horn stained with the pan-AMPAr antibody (pAMPA) or with one of the subunit-specific antibodies. As we have 
reported previously [60], lamina I is relatively thick in this region. Images of pan-AMPAr, GluR1 and GluR2 are taken from one 
section, while those for GluR3 and GluR4 are taken from another. GluR1 puncta are most numerous in laminae I and II, while 
those that are GluR2- or GluR3-immunoreactive are present in large numbers throughout laminae I–III. The GluR4 staining 
was obtained with a rabbit antibody against the C-terminal part of the protein (GluR4-C antibody), and is present at relatively 
few puncta in laminae I and II. However some clusters of GluR4 puncta that are orientated either transversely (arrow) or dor-
soventrally (arrowhead) are visible in the superficial dorsal horn. Each image was obtained from a projection of 5 optical sec-
tions at 0.3 µm z-spacing. Approximate locations of laminar boundaries are shown. Scale bar = 20 µm.Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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99%) of these puncta were positive for GluR2 in sections
from the 4 rats.
Since the quantification of GluR1 and GluR3 was carried
out on the same set of sections, we were able to analyse
the co-localisation of these two subunits. We found that
the great majority (89–92%) of pan-AMPAr-positive
puncta throughout laminae I–III were stained with either
GluR1 or GluR3, while 25–37% contained both types of
immunoreactivity (Fig. 3a–d, Table 2). However, most of
the puncta that were strongly immunoreactive for GluR1
were either weakly stained or unstained with the GluR3
antibody, and vice versa. Approximately 10% of the pan-
AMPAr-positive puncta in laminae I–III in these sections
were not immunostained with either GluR1 or GluR3
antibodies (Table 2).
Since both the GluR1 and GluR4-C antibody were raised
in rabbit, we used a two-stage immunocytochemical pro-
cedure to look for possible co-existence between these
subunits in lamina I. This region was chosen since it has a
significant population of puncta that are immunoreactive
with each of these antibodies, and because it also contains
a relatively high density of projection neurons (see
below). We found that the great majority of GluR4-immu-
noreactive puncta in lamina I were not labelled by the
GluR1 antibody (Fig. 4), although a small proportion
(mean 3.9%, range 1.5–6.9%, n = 3) also showed GluR1-
immunoreactivity.
Although puncta immunoreactive with the GluR4-C anti-
body were relatively infrequent in laminae I–II, those that
were present were often strongly immunoreactive and
arranged in rows or clusters. Some of these were restricted
to lamina I and were transversely (Fig. 1 arrow) or longi-
tudinally orientated, while others that had a dorsoventral
orientation were seen in laminae I, II or III (Fig. 1 arrow-
head). Close inspection revealed that these clusters of
bright puncta were frequently arranged in parallel rows
which appeared to outline dendritic shafts (Fig. 5a). Those
in lamina I were usually also strongly stained with the
GluR3 antibody (Fig. 5b–c), while the dorsoventrally ori-
entated ones in laminae II or III were generally either
weakly stained or unstained with the GluR3 antibody
(data not shown).
AMPAr staining in KO mice
Sections from mice in which the GluR1-3 subunits had
been knocked out and from corresponding wild-type ani-
mals were stained to reveal GluR1, GluR2 and GluR3, and
the results are illustrated in Fig. 6. Sections from wild-type
mice showed punctate staining with each of the 3 anti-
bodies, and the laminar distribution resembled that seen
in the rat dorsal horn. In each of the knock-outs staining
with the antibody corresponding to the product of the
deleted gene was completely absent, while an apparently
normal pattern of punctate staining was detected with the
other two antibodies.
PSD-95 and its relation to pan-AMPAr staining
Following antigen retrieval with pepsin, the PSD-95 anti-
body gave a punctate staining pattern in the rat dorsal
horn, which was similar to that seen with the pan-AMPAr
and GluR2 antibodies (Fig. 7a). Puncta were present
Comparison of immunostaining with the GluR4-C and GluR4-N antibodies Figure 2
Comparison of immunostaining with the GluR4-C and GluR4-N antibodies. Confocal images from lamina I stained 
with the GluR4-C, GluR4-N and GluR2 antibodies. A few puncta are labelled with the GluR4-C antibody (two marked with 
arrows). The GluR4-N antibody stains these strongly, but also labels several other puncta more weakly (two shown with 
arrowheads). All of the puncta labelled by each GluR4 antibody are GluR2-immunoreactive. Images were obtained from 4 opti-
cal spacing at 0.3 µm. Scale bar = 10 µm.Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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throughout the grey matter of the spinal cord, but were
densest in the superficial dorsal horn (laminae I–II). In
sections from PSD-95-mutant (but not wild-type) mice,
staining with the PSD-95 antibody was absent, while
staining with GluR2 antibody in the same sections was
apparently normal (Fig. 7b–g).
In each of 3 rats, we analysed 100 pan-AMPAr-immunore-
active puncta from laminae I–III and found that virtually
all of them (mean 99.7%, range 99–100) were also posi-
tive for PSD-95 (Fig. 8). We also found that 97.7% (96–
99%) of PSD-95-immunoreactive puncta were labelled
with the pan-AMPAr antibody.
Discussion
The main novel findings of this study are (1) that GluR1
is present at the majority of AMPAr-containing synapses
(~65%) in laminae I–II, where it is invariably co-localised
with GluR2 and often with GluR3, and (2) that antibody
against the C-terminal part of GluR4 labels relatively few
Table 1: Percentages of pAMPAr-positive puncta with different AMPAr subunits. Percentage of AMPAr-positive puncta in each lamina 
that were immunopositive with GluR1, GluR3 and GluR4-C antibodies. Each represents the mean value from 4 rats with the range 
given in brackets.
subunit
Lamina GluR1 GluR3 GluR4
I6 4   (59–68) 65 (54–70) 23 (15–34)
IIo 66 (58–70) 57 (54–63) 7 (3–10)
IIi 63 (57–70) 57 (53–59) 9 (5–11)
III 34 (27–42) 80 (76–86) 46 (38–54)
Staining with GluR1-4 and pan-AMPAr antibodies Figure 3
Staining with GluR1-4 and pan-AMPAr antibodies. Confocal images that show immunoreactivity for GluR1, GluR3 and 
pan-AMPAr (pAMPA) in lamina I (a-d), and GluR2, GluR4 and pan-AMPAr in lamina III (e-h). In each case a merged image is 
shown (d,h). Note that all puncta labelled with the GluR1-4 antibodies are also labelled with the pan-AMPAr antibody. a-d: 
Although most of the puncta that are strongly labelled with the GluR1 or GluR3 antibody are weakly labelled or negative with 
the other one, some can be seen to contain immunostaining for both subunits (2 shown with arrows). e-f: All of the puncta 
that are GluR4-positive are also labelled with the GluR2 and pan-AMPAr antibodies. The images are projections of 2 optical 
sections at 0.35 µm z-spacing. Scale bar = 10 µm.Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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synapses in the superficial laminae, with those in lamina
I being largely separate from GluR1-containing puncta.
We confirm that virtually all AMPAr-containing synapses
in the superficial dorsal horn possess GluR2 subunits. We
also provide further evidence that the staining seen with
AMPAr antibodies after antigen retrieval corresponds to
synaptic receptors, by demonstrating a high degree of co-
localisation with the postsynaptic density protein PSD-95,
and by showing that punctate staining with GluR1-3 anti-
bodies is absent in tissue from corresponding knock-out
mice.
PSD-95 in the dorsal horn
PSD-95, a member of the membrane-associated guanylate
kinase (MAGUK) family, is a major constituent of the
post-synaptic density at glutamatergic synapses, and con-
tains domains that are involved in protein-protein inter-
actions. PSD-95 is known to play an important role in
NMDA receptor-mediated synaptic plasticity [43-45], and
in the spinal cord it appears to be necessary for the devel-
opment of neuropathic pain following peripheral nerve
injury [46,47], although not for inflammatory pain [47].
There have apparently been few studies of the distribution
of PSD-95 in the spinal cord, although Tao et al. [48] used
an immunocytochemical method without antigen
retrieval and reported staining that was densest in laminae
I and IIo, while Garry et al. [47] observed β-galactosidase
activity associated with PSD-95 expression that was
restricted to neurons in lamina II. Fukaya and Watanabe
[40] demonstrated that treatment of sections with pepsin
prior to immunocytochemistry unmasks epitopes and
allows detection of MAGUK proteins in the post-synaptic
density, whereas these were not visualised reliably with
conventional methods. It is therefore likely that the punc-
tate pattern that we have demonstrated corresponds to the
distribution of PSD-95 in the post-synaptic densities of
glutamatergic synapses, and the finding that this staining
was absent in PSD-95 mutant mice confirms that the anti-
body is specific for the protein. Interestingly, the antibody
that we used was raised against the N terminal portion of
PSD-95, which is intact in the mutant mouse. Migaud et
al. [43] demonstrated that a truncated form of the protein,
known as PSDPDZ12, was synthesised in these animals.
However, they concluded that this was not localised to
post-synaptic densities, and our results confirm this inter-
pretation.
The almost perfect co-localisation of PSD-95- and pan-
AMPAr-immunostaining seen in the present study
strongly suggests that both proteins are expressed at virtu-
ally all glutamatergic synapses in the superficial dorsal
horn in the adult rat. Although it is possible that there is a
population of glutamatergic synapses that lack both pro-
teins, there is apparently no evidence to support such a
suggestion.
Comparison with previous findings
Although we did not determine the percentage of gluta-
matergic synapses that expressed GluR1 in our previous
study [33] we did estimate that this subunit was present at
30–40% of synapses associated with terminals that con-
tained VGLUT1 or were derived from unmyelinated pri-
mary afferents in laminae I–II, and at ~15% of the
Immunostaining for GluR1 and GluR4 in lamina I Figure 4
Immunostaining for GluR1 and GluR4 in lamina I. 
Confocal images that show immunoreactivity for GluR1 and 
GluR4, together with a merged image (right). Note that in 
this field the two types of immunoreactivity are contained in 
different puncta, with no co-localisation. This is a projection 
of 16 optical sections at 0.3 µm z-spacing. Scale bar = 5 µm.
Table 2: Co-localization of GluR1 and GluR3. Percentage of AMPAr-positive puncta in each lamina that showed different patterns of 
immunoreactivity for GluR1 and GluR3. Each represents the mean value from 4 rats with the range given in brackets.
Lamina GluR1+/GluR3+ GluR1+/GluR3- GluR1-/GluR3+ GluR1-/GluR3-
I 37 (32–44) 27 (24–35) 28 (22–33) 8 (6–11)
IIo 32 (27–36) 34 (25–41) 25 (20–30) 9 (5–12)
IIi 31 (26–35) 32 (28–35) 26 (22–29) 11 (8–16)
III 25 (21–28) 9 (4–14) 56 (49–65) 11 (6–17)Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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synapses formed by VGLUT2-containing boutons in these
laminae. However, in the present study we found that
~65% of puncta in these laminae were GluR1-immunore-
active. In both the quantitative analysis of GluR1 in our
previous study [33] and also in the present study, we used
the same GluR1 antibody and detected this with a Cy5-
conjugated secondary antibody. However, in the present
study the Cy5 fluorescence was revealed with a highly sen-
sitive gallium arsenide phosphide (GaAsP) PMT, and the
improved sensitivity probably accounts for the much
higher expression that we observed here.
In contrast, we found that only 7–23% of puncta in lami-
nae I and II were immunoreactive with an antibody
against the C-terminal portion of GluR4, whereas in our
previous study we reported that more than 40% of puncta
in these laminae were stained with the GluR4-N antibody
[33]. This discrepancy resulted from the relatively weak
staining by the GluR4-N antibody of many puncta that
were negative with the GluR4-C antibody, as shown in
Fig. 2. There are a number of possible explanations for the
difference in staining patterns between the two antibod-
ies. Firstly, the GluR4-N antibody may cross-react with
another protein, for example one of the other AMPAr sub-
units. This seems very unlikely since in the hippocampus
staining with this antibody is restricted to the dendrites of
interneurons, and is not seen on pyramidal cells, which
express GluR1, 2 and 3 subunits (M.W. unpublished
observations). Alternatively, it may be that immunostain-
ing with the GluR4-N antibody is more sensitive, resulting
in identification of a population of puncta that are below
the detection threshold with the GluR4-C antibody. How-
Immunostaining for GluR2, GluR3 and GluR4 in lamina I Figure 5
Immunostaining for GluR2, GluR3 and GluR4 in lamina I. a: A confocal image from a parasagittal section, showing a 
cluster of GluR4-immunoreactive puncta that appear to outline a single dendrite in lamina I. The boxed area is shown in b-e. b-
e: part of the field shown in a, scanned to reveal GluR4, GluR3 and GluR2, together with a merged image. The GluR4-positive 
puncta are also GluR2- and GluR3-immunoreactive, and 2 of these are indicated with arrows. This is a projection of 19 optical 
sections at 0.3 µm z-spacing. Scale bar = 10 µm.Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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ever, we found that the puncta that are positive with the
GluR4-C antibody in laminae I–II were often very strongly
labelled, which argues against this explanation. Nonethe-
less, it is possible that the difference in location of the
epitopes (extracellular for GluR4-N, intracellular for
GluR4-C) is a contributory factor. A third explanation is
that the alternatively spliced short form of GluR4
(GluR4c) [49], which lacks the epitope recognised by the
GluR4-C antibody, is expressed at some synapses in the
superficial dorsal horn that have undetectable levels of the
long form of GluR4. As far as we are aware, there is little
evidence available concerning the expression of GluR4c in
the spinal cord, although Kawahara et al. [50] have esti-
mated that approximately 10% of the mRNA for GluR4 in
adult human spinal grey matter is the GluR4c form. What-
ever the explanation, the present findings suggest that the
Immunostaining for GluR1, GluR2 and GluR3 in AMPAr knock-out and wild-type mice Figure 6
Immunostaining for GluR1, GluR2 and GluR3 in AMPAr knock-out and wild-type mice. Confocal images showing 
parts of the superficial dorsal horn from a wild-type (w.t.) mouse and from mice in which the genes coding for GluR1, GluR2 
and GluR3 (gria1, 2 and 3) had been knocked out. Each row shows staining in a different mouse, and in each case staining for 
GluR1 (red) is shown in the left column, followed by staining for GluR2 (blue) and GluR3 (green), with a merged image in the 
right column. Note the lack of staining for the corresponding subunit in each of the knock-out mice. Images show projections 
of 8 optical sections at 0.3 µm z-separation. Scale bar = 5 µm.Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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long form of GluR4 is highly expressed in only a small
proportion of synapses in the superficial dorsal horn.
AMPAr subunit expression at synapses in the superficial 
dorsal horn
Our results suggest that the great majority of cells with
dendrites in laminae I and II express GluR2 together with
either or both of the GluR1 and GluR3 subunits (and pos-
sibly low levels of GluR4c). Approximately 10% of puncta
were found to lack both GluR1- and GluR3-immunoreac-
tivity, and these may correspond to those that express the
GluR4 subunit. Alternatively, it may be that these syn-
apses do contain GluR1 or GluR3, but at levels that were
below the detection threshold with the methods used in
this study.
The finding that ~65% of puncta in laminae I–II were
GluR1-immunoreactive suggests that this subunit is
expressed by the majority of cells in these laminae. There
are several lines of evidence to suggest that this subunit
plays a role in synaptic plasticity in the dorsal horn in pain
states. Zhou et al. [51] observed a rapid up-regulation of
GluR1 mRNA in the lumbar dorsal horn following injec-
tion of complete Freund's adjuvant into the hindpaw,
while Fang et al. [52] reported phosphorylation of this
subunit at both S831 and S845 sites in Western blots of
spinal cord tissue after intradermal capsaicin injection.
We were able to demonstrate S845 phosphorylation of
GluR1 at synapses in laminae I–II of the ipsilateral dorsal
horn after capsaicin injection [33]. In addition, it has been
reported that GluR1-containing receptors can be recruited
to neuronal plasma membranes in lumbar spinal cord fol-
lowing a noxious visceral stimulus [53]. Synaptic plastic-
ity involving GluR1 could therefore potentially occur in a
high proportion of neurons in the superficial dorsal horn.
Interestingly, the GluR4-C-immunoreactive puncta seen
in laminae I and II were often arranged in clusters, and in
fortuitous sections these appeared to outline parts of the
dendritic trees of individual neurons, as shown in Fig. 5.
These neurons are presumably relatively infrequent (since
only a few clusters were observed in each section) and
have a high density of glutamatergic synapses on their
dendritic trees. The arrangement of puncta indicated that
the dendrites were often of relatively large diameter. The
clusters of GluR4-immunoreactive puncta seen in lamina
I may belong to projection cells, which are thought to
make up approximately 5% of the neuronal population in
this lamina [54]. Projection cells with the neurokinin 1
(NK1) receptor have been shown to have a high density of
synaptic input from substance P-containing primary affer-
ents (which are also glutamatergic) [12], and we have
recently observed that a population of large projection
cells that lack the NK1 receptor [55] receive numerous
contacts from VGLUT2-immunoreactive boutons on their
dendritic trees (AJT and EP, unpublished observations).
Dorsoventrally-orientated clusters of GluR4-C-immuno-
reactive puncta were also seen in laminae II and III, and
these may represent either the ventrally directed dendrites
of lamina I cells or else dorsal dendrites of cells located in
deeper laminae. Projection neurons in laminae III and IV
that express the NK1 receptor have been shown to have
dorsally directed dendrites that extend into lamina I [6],
and these are known to have a high density of synaptic
PSD-95 immunostaining in dorsal horn Figure 7
PSD-95 immunostaining in dorsal horn. a: The distribu-
tion of PSD-95-immunoreactivity in the rat dorsal horn fol-
lowing antigen retrieval with pepsin. Approximate positions 
of the laminae are shown. Punctate staining for PSD-95 is 
present throughout the dorsal horn, with the highest density 
in the superficial part (laminae I–II). b-g show immunostain-
ing for GluR2 (green) and PSD-95 (red) in lamina II in a wild-
type mouse (b-d) and in a PSD-95 mutant mouse (e-g). Note 
the lack of punctate staining for PSD-95 in the PSD-95 
mutant. All images are from single optical sections. Scale bars 
= 50 µm (a), 10 µm (b-g).Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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input from substance P-containing afferents [56]. It is
therefore possible that some of the clusters of GluR4-
immunoreactive puncta are associated with these cells.
Since the majority of glutamatergic synapses in lamina I
appear to contain GluR1, it is likely that some of the pro-
jection neurons in this lamina express this subunit. How-
ever, these would belong to a different population to
those that express GluR4, since the 2 subunits were very
seldom colocalised. It has been shown that lamina I pro-
jection neurons can develop LTP following either high or
low-frequency stimulation of primary afferents [57,58].
Activity-dependent insertion of AMPArs that contain
either GluR1 or GluR4 is thought to underlie certain
forms of LTP, and it is therefore likely that either GluR1-
or GluR4-containing receptors are responsible for this
phenomenon in lamina I projection cells.
Conclusion
Our results provide further confirmation that the immu-
nostaining seen in the spinal dorsal horn with antibodies
against AMPArs, following antigen retrieval with pepsin,
represents receptors located at glutamatergic synapses.
They show that the majority of such synapses in laminae
I–III contain GluR2 with either or both of GluR1 and
GluR3 subunits. In contrast, the long form of the GluR4
subunit has a much more restricted distribution in the
superficial dorsal horn, and appears to be associated with
specific types of neuron, many of which also express
GluR2 and GluR3, but not GluR1. These neurons may cor-
respond, at least in part, to lamina I projection cells. The
high degree of co-localisation of pan-AMPAr staining with
that for PSD-95 suggests that virtually all glutamatergic
synapses in this region contain AMPArs in the adult spinal
cord.
Methods
Animals
Eighteen adult male Wistar rats (Harlan, Loughborough,
UK; 230 – 300 g) were deeply anaesthetised with pento-
barbitone and perfused through the left ventricle with
Ringer's solution followed by 4% freshly depolymerised
formaldehyde. Lumbar segments (L2–L5) were removed,
stored in the same fixative for 5–8 hours and then cut into
transverse or parasagittal 60 µm thick sections with a
Vibratome. In addition, spinal cord tissue that had been
fixed according to the same protocol was obtained from
adult mice of either sex that lacked the genes for GluR1
(gria1-/-), GluR2 (gria2-/-) or GluR3 (gria3-/-), or had a
mutation affecting the gene coding for PSD-95 [43],
together with tissue from corresponding adult wild-type
mice. The mouse spinal cords were cut with a Vibratome
into transverse 60 µm thick sections. Sections were rinsed
for 30 mins in 50% ethanol to enhance antibody penetra-
tion.
All experiments were approved by the Ethical Review
Process Applications Panel of the University of Glasgow,
and were performed in accordance with the European
Community directive 86/609/EC and the UK Animals
(Scientific Procedures) Act 1986. All efforts were made to
minimize the number of animals used and their suffering.
Immunocytochemistry
All sections underwent antigen retrieval with pepsin prior
to immunocytochemical processing [33,38]. This
involved incubating the sections at 37°C for 30 mins in
PBS followed by 10 mins in 0.2 M HCl containing 1 mg/
ml pepsin (Dako, Glostrup, Denmark). They were then
reacted for double- or triple-immunofluorescence label-
ling with various combinations of antibodies directed
Co-localisation of PSD-95 and pan-AMPAr in lamina II Figure 8
Co-localisation of PSD-95 and pan-AMPAr in lamina II. Confocal images showing the co-localisation of immunostaining 
for pan-AMPAr (pAMPA) and PSD-95 in lamina IIi. These images were projected from 2 optical sections at 0.3 µm z-separa-
tion. Scale bar = 5 µm.Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
Page 11 of 14
(page number not for citation purposes)
against AMPAr subunits or PSD-95 (see Table 3 for details
of the antibodies used and their concentrations). In most
cases, sections were incubated for 2–3 days at 4°C in a
cocktail of 2 or 3 primary antibodies (each raised in a dif-
ferent species), and then overnight at 4°C in species-spe-
cific secondary antibodies that were raised in donkey and
conjugated to either Alexa 488 (Invitrogen, Paisley, UK;
1:500), or to Rhodamine Red or Cy5 (Jackson Immunore-
search, West Grove, PA, USA; 1:100). For the sections that
were reacted with both GluR1 and GluR4-C antibodies a
different approach was used, since both of these antibod-
ies were raised in rabbit. In this case, sections were ini-
tially incubated for 1 day in GluR1 antibody followed by
1 day in Fab' fragment of donkey anti-rabbit IgG conju-
gated to Rhodamine Red (Jackson Immunoresearch;
1:100). They were then incubated in unlabelled Fab' frag-
ment of donkey anti-rabbit IgG (Jackson Immunore-
search; 1:20) for 2 hours (to block any binding sites on the
GluR1 antibody), followed by 3 days in rabbit anti-
GluR4-C and 1 day in Alexa 488-labelled donkey anti-rab-
bit IgG (Invitrogen; 1:500).
For all immunocytochemical reaction, the rinses were in
PBS with 0.3 M NaCl, and antibodies were diluted in PBS
that contained 0.3% Triton-X100. Sections were mounted
in anti-fade medium (Vectashield; Vector Laboratories,
Peterborough, UK) and stored at -20°C.
Antibodies
The goat GluR3 antibody was raised against glutathione S-
transferase fused to the C terminal residues 830–862 of
the mouse GluR3 subunit (GenBank accession number
AB022342) and affinity-purified using GST fusion pro-
tein-coupled cyanogen bromide-activated Sepharose 4B
(Amersham Biosciences, Bucks, UK) as described previ-
ously [33].
All of the other polyclonal antibodies used in this study
were also affinity-purified. The GluR1 antibody (Chemi-
con, Chandlers Ford, UK; cat no. AB1504) was raised
against a synthetic peptide corresponding to the last 13
amino acids of rat GluR1 and is reported to show no cross-
reactivity with other AMPAr subunits (manufacturer's
specification), while the monoclonal GluR2 antibody
(Chemicon, cat no. mab397, clone 6C4) has been exten-
sively characterised and shown not to detect other AMPA
or kainate subunits [59]. The GluR4-N antibody was
raised against residues 245–273 of mouse GluR4 and rec-
ognises a single protein band of ~98 kDa in Western blots
of the PSD fraction from mouse spinal cord [33]. Staining
with this antibody is blocked by pre-incubation with the
immunising peptide [33]. The GluR4-C antibody (Labvi-
sion, Fremont, CA, USA; cat no. RB-9059) was raised
against a peptide derived from the C-terminal of human
GluR4 and recognises a single band of ~105 kDa in West-
ern blots of rat brain lysates (manufacturer's specifica-
tion). The PSD-95 antibody was raised against the N-
terminal region (residues 1–64) of mouse PSD-95 and
recognised a band of 87–97 kDa on Western blots of rat
brain homogenates [40]. Finally, the pan-AMPAr anti-
body was raised against residues 717–745 of the mouse
GluR1 (a region that shows high sequence homology
between the GluR1-GluR4 subunits) and detected each of
the four AMPAr subunits in transfected cells, with a trace
of cross-reactivity to the kainate receptor subunit GluR6
[39].
Confocal microscopy and Analysis
Sections were scanned with a Bio-Rad Radiance 2100 con-
focal microscope with Argon, HeNe and red diode lasers,
or a Bio-Rad MRC1024 confocal with a Krypton-Argon
laser. All of the analysis was carried out on stacks of con-
focal images scanned sequentially (to avoid fluorescent
bleed-through) with a 60× oil-immersion lens and a z-
separation of 0.3 or 0.35 µm.
Analysis of the percentage of AMPAr puncta that were
immunolabelled for GluR1, GluR3 or GluR4 was carried
out on sections from 4 rats. From each rat, one section
that had been reacted with pan-AMPAr, GluR1 and GluR3
antibodies, and one that had been reacted with pan-
AMPAr and GluR4-C antibodies was selected. From each
section, a set of confocal scans covering a ~100 µm wide
strip through the entire dorsoventral extent of laminae I–
III was obtained. The lamina I/II and II/III borders were
identified by examining sections through a dark-field con-
denser [60], while the lamina III/IV border was deter-
mined by reference to an atlas of rat spinal cord [61].
Table 3: Characteristics of primary antibodies used in this study
Antibody Source Species, Type Dilution Reference
GluR1 Chemicon Rabbit, polyclonal 1:500
GluR2 Chemicon Mouse, monoclonal 1:300 [59]
GluR3 M. Watanabe Goat, polyclonal 1:500
GluR4-N M. Watanabe Guinea pig, polyclonal 1:500 [33]
GluR4-C LabVision Rabbit, polyclonal 1:100
pan-AMPAr M. Watanabe Guinea pig, polyclonal 1:100 [39]
PSD-95 M. Watanabe Rabbit, polyclonal 1:200 [40]Molecular Pain 2008, 4:5 http://www.molecularpain.com/content/4/1/5
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Lamina II was divided into outer (IIo) and inner (IIi) parts
by drawing a line midway between the I/II and II/III bor-
ders. pan-AMPAr-immunostaining in confocal scans was
examined with MetaMorph software (Universal Imaging,
Downington, PA, USA) and immunoreactive puncta were
initially selected by using a grid [33]. This was done in
such a way as to ensure that puncta through the full dors-
oventral extent of each lamina were selected. From each
section, 400 pan-AMPAr-labelled puncta were selected
(100 each from laminae I, IIo, IIi and III) and these were
then examined to determine whether they were immuno-
reactive with the GluR1, GluR3 or GluR4 antibodies.
Examination of sections that had been reacted with pan-
AMPAr antibody and GluR2 revealed an almost perfect
co-localisation throughout laminae I–III. We therefore
used a modification of the approach described above, in
which 100 pan-AMPAr puncta were selected from the full
dorsoventral extent of this region in a single section each
from 4 rats and examined for the presence of GluR2.
To determine the extent of GluR1 and GluR4 co-localisa-
tion in lamina I, confocal scans were obtained from 4 sec-
tions each from 3 rats. The confocal images representing
GluR4 were initially examined with Neurolucida for Con-
focal (MicroBrightField Inc., Colchester, VT, USA) and at
least 25 GluR4-immunoreactive puncta were selected
from each section. Confocal images representing both
types of immunoreactivity were then merged and the pres-
ence or absence of GluR1-immunostaining in each of the
selected puncta was recorded.
To investigate co-localisation of AMPArs with PSD-95,
one section that had been reacted with pan-AMPAr and
PSD-95 antibodies was selected from each of 3 rats. In
each case a set of confocal images was scanned to produce
a ~100 µm-wide strip through the full extent of laminae I–
III. One hundred PSD-95-immunoreactive puncta were
initially selected from the full dorsoventral extent of this
region and examined to determine whether they were also
pan-AMPAr-immunoreactive. A similar approach was
then used to determine the proportion of pan-AMPAr-
immunoreactive puncta that were labelled with the PSD-
95 antibody. In each case, the selection of puncta was
made while the observer was blind to the other type of
immunostaining.
Immunostaining of mouse tissue
Sections from gria1-/-, gria2-/- and gria3-/- mice (n = 2 for
each mutation) and appropriate wild-type animals were
reacted with antibodies against GluR1, GluR2 and GluR3,
while those from 3 PSD-95-mutant and wild-type mice
were reacted with PSD-95 and GluR2 antibodies.
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